Journal of Acute Care

Register      Login

VOLUME 3 , ISSUE 2 ( May-August, 2024 ) > List of Articles

TUTORIAL

The Bubble Test for Diagnosis of Hepatopulmonary Syndrome

Amrita Shah, Ipe Jacob, Karthik Rao, Karthik Vasudevan, Sohini Roy, Megha Vadakunthani Sethumadhavan

Keywords : Bubble test, Chronic liver disease, Contrast echocardiography, Hepatopulmonary syndrome, Refractory hypoxemia, Right-to-left shunt

Citation Information : Shah A, Jacob I, Rao K, Vasudevan K, Roy S, Sethumadhavan MV. The Bubble Test for Diagnosis of Hepatopulmonary Syndrome. 2024; 3 (2):101-104.

DOI: 10.5005/jp-journals-10089-0117

License: CC BY-NC 4.0

Published Online: 19-08-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Hepatopulmonary syndrome (HPS) is a condition characterized by hypoxemia with partial pressure of oxygen (PaO2) <80 mm Hg or alveolar–arterial oxygen gradient (A-aO2) ≥15 mm while breathing room air, pulmonary vascular dilation, and portal hypertension (with or without cirrhosis). The incidence ranges from 5 to 32% in cirrhosis patients. The hypoxia associated with HPS is usually refractory to increasing concentrations of oxygen indicating an underlying right-to-left shunt. An echocardiogram bubble study is used to differentiate between intrapulmonary or intracardiac right-to-left shunt.


PDF Share
  1. Khan AN, Al-Jahdali H, Abdullah K, et al. Pulmonary vascular complications of chronic liver disease: pathophysiology, imaging, and treatment. Ann Thorac Med 2011;6(2):57–65. DOI: 10.4103/1817-1737.78412
  2. Bansal K, Gore M, Mittal S. Hepatopulmonary Syndrome. Treasure Island (Florida): StatPearls Publishing; 2024.
  3. Gupta SK, Shetkar SS, Ramakrishnan S. Saline contrast echocardiography in the era of multimodality imaging—importance of “bubbling it right”. Echocardiography 2015;32:1707–1719. DOI: 10.1111/echo.13035
  4. Macêdo LG, Lopes EP. Hepatopulmonary syndrome: an update. Sao Paulo Med J 2009;127(4):223–230. DOI: 10.1590/s1516-31802009000400008
  5. Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right–to–left shunting in end–stage hepatic disease. Am J Cardiol 1992;70(4):516–519. DOI: 10.1016/0002-9149(92)91200-n
  6. Bernard S, Churchill TW, Namasivayam M, et al. Agitated saline contrast echocardiography in the identification of intra- and extracardiac shunts: connecting the dots. J Am Soc Echocardiogr 2020;23:S0894–7317(20)30615-5. DOI: 10.1016/j.echo.2020.09.013
  7. Raevens S, Boret M, Fallon MB. Hepatopulmonary syndrome. JHEP Rep 2022;4(9):100527. DOI: 10.1016/j.jhepr.2022.100527
  8. Krowka MJ, Fallon MB, Kawut SM, et al. International Liver Transplant Society Practice Guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 2016;100(7):1440–1452. DOI: 10.1097/TP.0000000000001229
  9. Silvestry FE, Cohen MS, Armsby LB, et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 2015;28(8):910–958. DOI: 10.1016/j.echo.2015.05.015
  10. Tumgor G. Cirrhosis and hepatopulmonary syndrome. World J Gastroenterol 2014;20(10):2586–2594. DOI: 10.3748/wjg.v20.i10.2586
  11. Fuhrmann V, Drolz A, Rutter K, et al. HPS: diagnosis, clinical features, and medical therapy. Clin Liver Dis (Hoboken) 2014;4(2):46–49. DOI: 10.1002/cld.402
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.